AVI Biopharma, Inc. (AVII) Tops Q1 Views

May 5, 2011 4:08 PM EDT
AVI Biopharma, Inc. (NASDAQ: AVII) reported Q1 EPS of $0.02, $0.05 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.55 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings